Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balances at Dec. 31, 2020 $ 21,147 $ 7 $ 174,342 $ (153,202)
Balance (in shares) at Dec. 31, 2020   3,189    
Common stock issued, net 65   65  
Common stock issued, net (in shares)   35    
Stock-based compensation 1,169   1,169  
Stock-based compensation (In shares)   35    
Net loss (7,236)     (7,236)
Balances at Mar. 31, 2021 15,145 $ 7 175,576 (160,438)
Balance (in shares) at Mar. 31, 2021   3,259    
Balances at Dec. 31, 2021 13,673 $ 8 191,937 (178,272)
Balance (in shares) at Dec. 31, 2021   7,010    
Common stock and warrants issued, net 9,740 $ 2 9,738  
Common stock and warrants issued, net (in shares)   25,248    
Warrants exercised 25   25  
Warrants exercised (in shares)   50    
Restricted stock awards cancelled   (7)    
Stock-based compensation 165   165  
Net loss (5,495)     (5,495)
Balances at Mar. 31, 2022 $ 18,108 $ 10 $ 201,865 $ (183,767)
Balance (in shares) at Mar. 31, 2022   32,301